- The $15 Billion Patent-Play In Trovagene
- Ex-Rabbi Turned Investment Manager Spots Information Arbitrage In These 2 Companies
- Trovagene Poised To Lead The Next Generation Of Molecular Diagnostics Technology
- What This News Means For Healthcare Stocks
- Repros Therapeutics: More Holes Than A Block Of Swiss Cheese
Timeless Wealth
Timeless Wealth
Send Message
Timeless Wealth
Stop FollowingTimeless Wealth
ABOUT
Timeless Wealth is a leading Publisher of Investment-Opinion content supported by research. We utilize a mix of fundamental and behavioral analysis to uncover undervalued investment opportunities in the small cap sector.
Follow us on twitter: https://twitter.com/#!/TimelessWealth
Follow us on twitter: https://twitter.com/#!/TimelessWealth
SNAPSHOT
- Description: Newsletter author. Trading frequency: Daily
- Interests: Dividend stock ideas & income, Gold, Stocks - long, Stocks - short, Tech stocks
COMPANY
BLOG
Currently, there are no blog details for Timeless Wealth.
Book
Currently, there are no book details for Timeless Wealth.
LATEST STOCKTALK
more »
$NBY trending just under its 200MA; 2012 should be an interesting yr for the firm, at least one partner suggests: http://bit.ly/vNchdH
Dec 22, 2011
Latest Comments
more »
- Per the CEO's comments on t... on Prolor Biotech: A Critical Year For Company Wit...
- Can you provide a link(s) t... on Trovagene Poised To Lead The Next Generation Of...
- "no physician in their... on Repros Therapeutics: More Holes Than A Block Of...
- UPDATE: Oculus priced an of... on Oculus: Financial Distress, Concentration Risk,...
- Len, this is very well writ... on NovaBay Anti-Infective Programs Mitigate Risk
Latest comments on Timeless Wealth's Articles
LATEST ARTICLES & INSTAPOSTS
more »

